Interim Effectiveness Estimates of 2023 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalizations - REVELAC-i Network, March-July 2023

Published on September 14, 2023

This report describes flu vaccine effectiveness data from five South American countries during the 2023 Southern Hemisphere flu season.

Continue reading on website
Other news

EARLY RELEASE: Interim Effectiveness Estimates of 2023 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalizations - REVELAC-i Network, March-July 2023

September 8, 2023
This report describes flu vaccine effectiveness data from five South American countries during the 2023 Southern Hemisphere flu season.

Now is the time for microbiome therapeutic innovation to combat antibiotic resistance

September 18, 2023
Before antibiotics, infectious diseases were the leading cause of death. Even routine medical procedures like dental work were far more dangerous. Antimicrobial resistance (AMR) is growing because of antibiotic overuse and misuse, undermining their effectiveness.Continue reading on website